Weijun Qin
- Urology top 5%
- Urinary Bladder and Prostate Research 6
- Nephrology top 10%
- Transplantation top 10%
-
- Immunotherapy and Immune Responses 4
- Rheumatology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 6
-
- Renal cell carcinoma treatment 5
-
- Hormonal Regulation and Hypertension 4
-
- Renin-Angiotensin System Studies 4
- Cited by
- UrologyNephrologyTransplantation
- Journals
- Angewandte Chemie International Edition (2 papers)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Weijun Qin
60 papers receiving 863 citations
Peers
Comparison fields: 5 of 107
- Urology 73
- Nephrology 74
- Transplantation 25
- Immunology 187
- Rheumatology 113
Countries citing papers authored by Weijun Qin
This map shows the geographic impact of Weijun Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijun Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijun Qin more than expected).
Fields of papers citing papers by Weijun Qin
This network shows the impact of papers produced by Weijun Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijun Qin. The network helps show where Weijun Qin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weijun Qin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 8 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 24 | |
| 10 | 2022 | 6 | |
| 11 | 2020 | 17 | |
| 12 | 2019 | 11 | |
| 13 | 2016 | 2 | |
| 14 | 2009 | 35 | |
| 15 | 2009 | 1 | |
| 16 | 2008 | 30 | |
| 17 | 2008 | 8 | |
| 18 | 2007 | 41 | |
| 19 | 2007 | 13 | |
| 20 | Necrosis and apoptosis induced by brucea javanica oil emulsion in bladder cancer cell | 2004 | 3 |
About Weijun Qin
Weijun Qin is a scholar working on Transplantation, Urology and Endocrine and Autonomic Systems, having authored 66 papers that have together received 881 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Urinary Bladder and Prostate Research (6 papers), CAR-T cell therapy research (6 papers), Renal cell carcinoma treatment (5 papers), Hormonal Regulation and Hypertension (4 papers), Renin-Angiotensin System Studies (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Urology (73 citations), Nephrology (74 citations) and Transplantation (25 citations). Weijun Qin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Weihong Wen, Fa Yang, Jianlin Yuan, Fuli Wang, Lijun Yang, Geng Zhang, Donghui Han, Jun Li, Fan Jun and X. Y.. Their work appears in journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.